Oklahoma City, OK, United States of America

Heather D Hickman

USPTO Granted Patents = 1 


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Heather D Hickman: Innovator in MHC Positive Cell Research

Introduction

Heather D Hickman is a prominent inventor based in Oklahoma City, OK (US). She has made significant contributions to the field of immunology through her innovative research and methodologies. Her work focuses on the isolation, purification, and identification of peptide ligands presented by MHC positive cells.

Latest Patents

Heather D Hickman holds 1 patent for her invention titled "Comparative ligand mapping from MHC positive cells." This patent relates to a methodology that allows for the isolation, purification, and identification of peptide ligands from soluble class I and class II MHC molecules. The invention is particularly relevant for identifying peptide ligands from uninfected, infected, or tumorgenic cells. This methodology enables the identification of these ligands and their corresponding source proteins, which can serve as markers for distinguishing between infected and uninfected cells, as well as tumorgenic and nontumorgenic cells. Such identification is crucial for targeting cells for therapeutic treatment or priming the immune response against infected cells.

Career Highlights

Heather D Hickman is affiliated with the University of Oklahoma, where she continues her research and development in the field of immunology. Her work has garnered attention for its potential applications in therapeutic treatments and immune response enhancement.

Collaborations

Heather has collaborated with notable colleagues, including William H Hildebrand and Rico Buchli, contributing to the advancement of research in her field.

Conclusion

Heather D Hickman is a dedicated inventor whose work in MHC positive cell research has the potential to impact therapeutic strategies significantly. Her innovative methodologies pave the way for advancements in immunology and targeted treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…